logo
Login
Open Account
Open Demat

Sector: Pharmaceuticals & Biotechnology

|

Large Cap

Zydus Lifesciences Share Price

Zydus Lifesciences Ltd.

₹875.60

4.40(0.51%)

Invest in ZYDUSLIFE with up to 4.00x margin.

Trade with MTF
1st Apr 2026 | 1:00 PM
NSE : ZYDUSLIFE
Open Free Demat Account

By signing up I certify terms, conditions & privacy policy

Zydus Lifesciences Performance

Price Movement

₹875.60

₹869.20

₹900.00

↘ Today's Low↗ Today's High

1 Year Performance

₹875.60

₹795.00

₹1059.05

↘ 52 Week Low↗ 52 Week High

Markets Today

High₹900.00
Low₹869.20
Open at₹888.00
Prev Close₹871.20
Volumes4.00 L
Avg Price₹883.19
Lower Circuit₹784.10
Upper Circuit₹958.30

Historical Performance

3M High₹947.55
3M Low₹855.95
1 Yr High₹1,059.05
1 Yr Low₹795.00
3 Yr High₹1,324.30
3 Yr Low₹484.95
5 Yr High₹1,324.30
5 Yr Low₹319.00

Zydus Lifesciences Fundamentals

Market Cap
High in industry
87,663.10 Cr.
PE Ratio (TTM)
Below industry Median
17.80
Dividend Yield
Above industry Median
1.30
Net Profit TTM
5.6% incr over last year
4,938.40
Net Profit Growth
5.6% incr over last year
4,938.40
PEG Ratio
High in industry
3.20
ROE
3% decr over last year
18.89
Operating Revenue TTM
26,089.30
Operating Revenue Growth
17.3% incr over last year
Book Value
Above industry Median
3.30
MFI
MFI is mid-range
42.13
RSI
RSI is mid-range
42.86
EPS (TTM)
44.97
Debt to Equity
0.13
Face Value
1
Operating Profit Margin Qtr.
30.02
Operating Profit Qtr.
1,816.40
Net Profit Qtr.
1,042.10
Operating Revenue Qtr.
6,864.50
PB Ratio
3.30

Zydus Lifesciences Financials

*All values are in Rs. Cr
Loading chart...
Indicator
Dec 2025
Sep 2025
Jun 2025
Mar 2025
Dec 2024
Total Revenue2,283.602,871.202,588.305,819.602,515.90
Operating Expense2,084.601,719.302,002.902,046.901,867.40
Operating Profit1991,151.90585.403,772.70648.50
Depreciation144.30136130128131.60
Interest116113.80137.60155.4097.20
Tax55.9028790.2086126.60
Net Profit296.501,156.60384.702,813.70470.60

ZYDUSLIFE Stock Recommendation by HDFC

View Call ↗

Research Type

Equity , Long Term

Buy Range

₹936 - ₹0

Target Price

₹1,000

Stop Loss

-

Target Date

10 Nov 26

Potential Returns

6.84 %

View Call ↗

Zydus Lifesciences Technicals

Zydus Lifesciences Ltd. EMA & SMA

₹875.60

-21.10 (-2.35%)

↗ Bullish Moving Average

0

↘ Bearish Moving Average

16

Day EMA5 ₹885.1
Day EMA10 ₹889.2
Day EMA12 ₹890.8
Day EMA20 ₹895.1
Day EMA26 ₹897.1
Day EMA50 ₹902.8
Day EMA100 ₹915.9
Day EMA200 ₹931.8

Zydus Lifesciences Support and Resistance

Resistance

First Resistance₹885.90
Second Resistance₹900.60
Third Resistance₹909.00

Support

First Support₹862.80
Second Support₹854.40
Third Support₹839.70

Technical Indicators

Day RSI42.86
Day MFI42.13
Day ADX18.95
Day Commodity Channel Index-123.80
William-83.11
Day MACD-6.30
Day MACD Signal Line-4.14
Day ATR22.73
Day ROC125-14.53
Day ROC21-5.27

Zydus Lifesciences Shareholding Pattern

Held BySep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Promoter757575757575
FII7.57.57.37.17.37.1
DII10.710.71111.210.911
Public6.86.86.76.76.86.9

Zydus Lifesciences Delivery And Volume

PeriodCombined Delivery VolumeNSE+BSE Traded Volume AvgDaily Avg Delivery Volume %
Day5.74 L11.49 L49.99%
Week4.21 L7.91 L53.23%
1 Month3.44 L6.58 L52.29%
6 Month4.07 L7.72 L52.66%

Zydus Lifesciences SWOT Analysis

Strengths14
Weakness8
Opportunity1
Threats3

Benjamin Graham Value Screen

Companies with current TTM PE Ratio less than 3 Year, 5 Year and 10 Year PE

Buy Zone: Stocks in the buy zone based on days traded at current PE and P/BV

Mid-range Performer (DVM)

Rising Net Cash Flow and Cash from Operating activity

Dividend yield greater than sector dividend yield

Effectively using its capital to generate profit - RoCE improving in last 2 years

Companies with Low Debt

Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years

Company able to generate Net Cash - Improving Net Cash Flow for last 2 years

Annual Net Profits improving for last 2 years

Book Value per share Improving for last 2 years

Companies with Zero Promoter Pledge

Volume Shockers

Zydus Lifesciences Corporate Action

Ex-Date
Dividend Amount
Dividend Type
Record Date
Instrument Type
25 Jul, 202511FINAL25 Jul, 2025Equity Share
26 Jul, 20243FINAL26 Jul, 2024Equity Share
28 Jul, 20236FINAL28 Jul, 2023Equity Share
28 Jul, 20222.5FINAL29 Jul, 2022Equity Share
28 Jul, 20213.5FINALEquity Share
23 Mar, 20203.5INTERIM24 Mar, 2020Equity Share
25 Jul, 20193.5FINALEquity Share
31 Jul, 20183.5FINALEquity Share
16 Mar, 20173.2INTERIM17 Mar, 2017Equity Share
17 Mar, 20163.2INTERIM18 Mar, 2016Equity Share

Zydus Lifesciences Stock Comparison

Financials
Anthem Biosciences Ltd.
J B Chemicals & Pharmaceuticals Ltd.
AstraZeneca Pharma India Ltd.
GlaxoSmithKline Pharmaceuticals Ltd.
Pfizer Ltd.
Abbott India Ltd.
Price (₹)₹674.40₹2,009.60₹7,867₹2,335.60₹4,833.30₹26,405
% Change2.77%-2.65%1.31%2.30%2.39%1.89%
Revenue TTM (₹ Cr)₹1,996.59₹4,193.04₹2,177.45₹3,800.74₹2,482.33₹6,824.13
Net Profit TTM (₹ Cr)₹484.66₹753.78₹200.89₹1,020.99₹853.55₹1,524.13
PE TTM76.1044.0096.6037.9025.3036.10
1 Year Return15.1327.18-9.78-20.7417.88-15.64
ROCE26.8824.69-57.0322.93-

FAQ's on ZYDUSLIFE

Desktop BannerMobile Banner
Invest Anytime, Anywhere
Play StoreApp Store
Open Free Demat Account Online

By signing up I certify terms, conditions & privacy policy